For Participants

How to apply

GPPAD available data (selection)

  • Genetic risk score and genotyping results from 40-50 SNPs used in the score from ~350000 newborns
  • OLINK®EXPLORE (3072 pnel) measured at birth in 770 POInT participants
  • Illumina Infinium Global Screening Array-24 from 770 POInT participants
  • Illumina Infinium MethylationEPIC Array measured in 749 POinT participants at age 1.5-2 years
  • Microbiome (16SV4/WGS Sequencing) in stool from 553 POInT participants at 2-3 years of age. For informationon additional metadata , please contact cc@gppad.org
Gppad Who we are Dr. Melanie Gündert

Scientists who are interested in collaborating with GPPAD and would like to receive data or biospecimens, please contact:

Dr. Melanie Gündert

Manuscript proposal submission form

Here you can download the GPPAD Manuscript Proposal Submission Form. Please refer to the GPPAD Publication Policy below before completing this form. Completed manuscripts proposals submission forms to be reviewed by the Publications & Presentations Committee should be sent to publications@gppad.org.

Publication Policy

External investigators must agree to conduct all research activities and manage all Intellectual Property in a manner that ensures open sharing of data as described below within the legal limits. It is the external investigators’ duty to comply with all applicable European, and GPPAD Consortium Member State, Data-Protection and Privacy-Protection Laws, Rules and Regulations then in effect.

Investigators’ obligations include:

a) Pseudonymized data generated through the use of GPPAD biobank material will be made available publicly no later than twelve months after the completion of the research activities.

b) Data will be maintained by GPPAD Data Share or by a third-party public repository for a period of at least 1 year following the first date on which the data was made publicly available.

Here you can download the following documents:

 

GPPAD Publication & Presentation Policy

GPPAD Publications Statement of Authorship

All manuscripts, abstracts, presentations, and press releases to be reviewed by the Publications & Presentations Committee should be sent to publications@gppad.org.

GPPAD data sharing policy

  1. GPPAD is required to execute a Data and Material Transfer Agreement for each approved ancillary project. A draft copy can be found HERE. In addition, investigators from third party countries (eg. USA, Australia) have to sign Standard Contractual Clauses Module one (HERE) or Standard Contractual Clauses Module two (HERE) and in some cases the execution of a Transfer Impact Assessment (TIA) might be required.
  2. Investigators agree to comply with all applicable European, and GPPAD Consortium Member State, Data-Protection and Privacy-Protection Laws, Rules and Regulations then in effect. If you have questions about GPPAD data and biobank sample sharing, please email us to cc@gppad.org.
  3. Investigators agree to conduct all research activities and manage all Intellectual Property in a manner that ensures open sharing of data. Investigators agree that generated data will be transferred back to GPPAD and stored at the GPPAD server.
  4. GPPAD is required to have a current Institutional Review Board (IRB)/ Ethical Board approval for each approved Investigator/project before any data or samples from the GPPAD biobank can be distributed; if not required by your IRB, please provide a letter from the IRB explaining that an approval is not required.
  5. Participation in GPPAD meetings and scientific discussion: Scientists who receive data or biomaterial are expected to report to GPPAD about the progress of the project, and participate in GPPAD meetings, and in scientific discussions during the collaboration.
  6. Funding for the analysis or biosample measurements must be secured.